chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 1054am, around 10 minutes after receiving vaccines, the patient was found by clinic staff in the lobby bathroom being brought to the floor by her mother. Mother stated patient vomited and now felt dizzy.  Upon arrival, patient was slowly brought to floor and placed on left side. 1st set of vitals obtained with the following data: BP 118/82; 110HR; 99% O2; blood glucose 117.  Nursing staff cleaned patient off and once assessed, set up to drink some apple juice.. Pt stated she felt better but just felt a little "shaky". Patient alert and oriented. She was conversing with myself and mild shaking noted in hands which quickly resolved as we continued talking.  Patient had just received TDaP, Polio, and Varicella around 10-15 minutes prior to episode.  Patient slowly assisted in standing and walked over to lobby where 3 nursing staff remained with patient and family. Mom, Dad, and sister present. At 1130am, patient left with family after she was cleared by staff to leave. Family counseled on any further side effects to call us or take her to see a provider for further assessment.   The following vitals were obtained: 11:04 BP 116/72; HR 104 99% O2 11:20am BP 102/76; HR 100; 99% O2
About 10 min after the in jection I started to feel nausea with a metal taste in my mouth. Then I stared to get a headache and tremors in my hands and arms.  After another 5 min I was getting mussel tightness in my face and throte.  I started to get dizzy and feel very cold.
Patient experienced stiffness of joints day vaccine administered and also felt nauseous, symptoms have improved but now experiencing redness and swelling on feet. Counseled patient to keep an eye on these symptoms and to report to MD if not improved within 2 days or worsened. Also counseled to contact MD if sudden change in mood/behavior or high fever occurs.
The patient stated that since he received his flu shot he has experienced pain in his left arm. He has sleep apnea as a result of his pain and a tingling sensation in his arm and fingertips. He began feeling these symptoms 3-4 days after the flu shot and the pain peaked on sun 11/14.
Received the Pfizer vaccine on April 13, 2021 (10 am) in the right arm.  Woke up the next day with a numb hand.  The numbness resolved temporarily, but a few days later experienced numbness and tingling in the entire arm as well as in the 4th and 5th fingers, along with a burning sensation in the right arm.  There was also some swelling and fullness in the hand, elbow, and upper arm.   Hand weakness and swelling in the lower forearm also occurred.  These symptoms persisted intermittently.  Went to see my doctor on April 26, 2021.  An Upper Extremity Ultrasound was performed to check for blood clots. The result was negative for Thrombus.  Advised to "wait and see" regarding the 2nd vaccine and to call if... ...other symptoms developed.   On May 1, 2021 had pain in left foot/ankle along with swelling.  Additionally, on May 4, 2021 pain and swelling developed in an area on the inside of the upper left leg.   Went to the doctor that morning (May 4th).  A Lower Extremity Ultrasound was performed to check for blood clots.  The result was negative for Thrombus.  Was advised to wait with the second vaccine for another week to see if symptoms would resolve.    As of May 15, 2021 symptoms continue, with intermittent swelling, numbness, and pain in the hand, elbow and arm.  Additionally, I have difficulty using my right hand due to continued weakness and numbness in the hand.   Since first seeing my doctor, I have been advised to take Motrin and/or Tylenol and apply heat and/or ice as needed for inflammation and pain.  Have been following this regimen for last few weeks with no significant improvement.  I have not received second vaccine, as symptoms still persist, and I have concerns that a similar or worse reaction may occur with the second dose.
Extreme Fatigue this morning had to go back to bed after eight hours sleep, Sore Arm,  Chills, Fever, Headache Cough
Approximately 35 minutes post-immunization, patient reported that he began experiencing tinnitus in his left ear.  Shortly thereafter, he returned to the pharmacy (approximately, 40 minutes after he began experiencing the symptoms) and he was still experiencing the tinnitus in his left ear at that point in time.  He stated that this is not something he has had occur previously.  He stated that he was not experiencing any additional symptoms at that point in time.  I advised patient to seek medical attention if the problem worsened, progressed, or continued into the next day.
Chronic Headaches/Migraines  and screaming loud tinnitus almost daily following my 2nd Phizer Vaccine in August 2021.  I wake up and go to bed with daily Headaches.  My scalp is always sore now and after brain scans, MRI and lab tests I still have no answers.
Asked to evaluate patient c/o palpitations after  moderna #1 dose. Pt awake and alert, HR 96/min, BP 160/100. ECG - NSR 96/min no acute ST-T changes. Pt rested and observed for 30 min. Palpitations slowly resolved. HR 89, BP 144/100 before leaving clinic. No cp, no sob or dizziness was experienced
low grade fever for 24 hours. moderate headache, light headedness &  fatigue for 24 hours.  sharp stomach/abdominal cramps for 6 hours. injection site tenderness ongoing.
He developed on the right chest, a circular rash that was painful to touch; A burning/pins and needles sensation after the vaccine on his left chest area/Abnormal sensation increased; A burning/pins and needles sensation after the vaccine on his left chest area; This is spontaneous report from a contactable Health care professional. A 20-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Formulation: Solution for injection Batch/Lot number: Not reported Expiration Date: Unknown ) via an unspecified route of administration, administered in Right Arm on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history concomitant medications were not reported. On an unspecified date, it was reported that two days after his first dose, the patient developed a circular rash on the right side of his chest, it proceeded to spread bigger, and was painful to the touch.  The rash later presented the same way on the left side of his chest, also very painful to the touch. The patient is due for his second dose tomorrow.  The caller would like to know if we have reports of a rash like this occurring, and if this is a contraindication to vaccination. A 20 y/o pt. received the Pfizer COVID-19 vaccine first dose and experienced pain a burning/pins and needles sensation after the vaccine on his left chest area. He received the vaccine on his right arm. She wants to provide updated information that there was no report of a rash or discoloration of the skin, as was reported in the crosslinked INT. The caller wanted to let Pfizer know that this was incorrect. She states the area of abnormal sensation increased, he went to the ER, had an EKG done (which resulted as normal) and was prescribed Valtrex. The sensation slowly improved. 2 days after stopping the Valtrex, he developed the abnormal sensation on the other side of his chest (right side). She wants to know if it is ok for him to get the second dose. The patient underwent lab tests and procedures which included electrocardiogram: normal on an unknown date 2021.Therapeutic measures were taken as a result of adverse event and treatment included Valtrex. Outcome of all events was recovered on an unspecified date.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Experienced neurological sensory change. Dr. describes these changes as "fleetingall over body stabbing pain."
4/11/2021: Sensation of something crawling on my skin.   About 5/5/2021, (after my second vaccine on 5/1/2021) a very itchy Chickenpox-looking rash broke our on my hands.  It started as prickly bumps that were not visible but they could be felt underneath my skin.  The prickly bumps are on my hands, arms, and legs.  I can feel them, but if I rub them the swell into a cluster of extremely itchy blisters.
On 10/09/2000 the health professional stated the patient "has varicella" with 12 lesions, 5 macular, papular and 6 crusted. Follow up information stated "pruritic fluid filled, red based lesions erupted on her face, back and groin. The patient has recovered.
Fever (subjective), nausea, vomiting, redness, tenderness, swelling, pain to injection site with redness spreading to majority of upper arm. Unable to raise affected arm past 90 degrees.
mom brought child in the office on 08/09/10 stated that on 8/6/10 she could not use her left side mom took child to Flordia hospital ER per mom they sent her home said she was ok.on 8/9/10 child was incontince of urine and had decreased tone,sensory and reflexes on left lower extremitys.Patient was addmitted to ST JOSEPH  Diagnosed with post polio enccphalomyelitis,post -polio vaccine
Patient called pharmacy three days after receiving vaccine to inform us that she still felt very weak after the vaccine and was in bed most of the time, although she reports being able to walk. She reports that four hours after receiving vaccine she was very weak and "freezing" and slept for four hours when she says she never naps. She says that her arm was really swollen at first but seems to be going down. She reports she has not had a fever but is very cold. She also reports she does not have an appetite. After being asked if she feels better or worse than the first day, she admits to slowly improving.
Information has been received from a registered nurse through the manufacturer pregnancy registry concerning a 29 year old Caucasian female with a history of 2 pregnancies (one live birth and one spontaneous aborting) who on 02-Oct-2002 and on 07-Nov-2003 was vaccinated with a first and second dose of varicella virus vaccine live (site unknown) (lot #643122/0549M) (0.5 mL), respectively. Other therapy included, sertraline HCl (Zoloft) 25 mg) (from 26-Nov-2002 to 05-Dec-2002) (number of dose taken = 9) and nitrofuratoin (MACROBID) (5X/BID number of 10). It was noted that when the patient was vaccinated there was no local reaction at vaccination site, varicella (chichen pox) symptoms post vaccination, or herpes zoster (shingles) symptoms post-vaccination. It was reported that the patient received the first dose "14 days before conception." On 02-Apr-2003 it was reported that "the patient is now 21 weeks pregnant" (LMP = 06-Nov-2003, EDD= 13-Aug-2003). On 31-Jan-2003 the patient had a first trimester screening which was reported to be "within normal limits" (Negative for Down's risk, negative for trisomy 18). On 05-Mar-2003 the patient's MSAFP was negative (negative for NTD). On 21-Mar-2003 an ultrasound was performed due to exposure to varicella virus vaccine live and was reported to be normal. On 02-Apr-2003 it was reported that "at this point, the fetus is experiencing a slow heart rate." The patient sought unspecified medical attention. On 07-Aug-2003, 39 weeks from LMP, the patient gave birth to a normal male weighing 7 pounds 13 ounces. There were no other reported complications during pregnancy, or complications during labor/delivery, and no reported diagnostic test during pregnancy. There were no reported infections or illnesses during pregnancy and there were no concurrent medical conditions during pregnancy. It was also noted that the patient had a spontaneous abortion 0n 27-Oct-2000 (8 weeks and 5 days from LMP). On 01-Jun-2001 the patient was tested for varicella antibodies prior to being vaccinated and was negative (non-reactive (.48)). It was noted that a birth defect did not occur in any past pregnancy. On 01-Oct-2001 the patient had given birth to a male, weighing 8 pounds 6 1/2 ounces, 39 weeks from LMP. The infant was reported to be normal. There was a reported C-section breech with this pregnancy. No further information is expected.
Moderna Vaccine was administered after the beyond use date of 30 days at refrigerated  tempature. Beyond use date 10/01/2021
Patient developed fever several hours after receiving vaccine. He was seen by his PCP on 10/29 and given antibiotics for a suspected sinus infection. Later that same day he developed seizures and was admitted to the hospital. A lumbar puncture was consistent with meningio encephalitis. He was intubated and placed on a ventilator on 10/31. Increased intracranial pressure required the placement of a ICP catheter on 11/2.  On 11/8 he was extubated and was responsive to painful stimuli. Discharge Summary received on 2/14/2005 states ADEM, aphasic, malnourished, meningitis, fever, bradycardia and nystagmus. As per annal follow up report: as of 12/06/2005 patient is permanently brain damaged, permanently mentally retarded and has seizures constantly.
Patient received the MMR vaccine, and was subsequently found to have a positive urine pregnancy test. The patient's last menstrual period was 3/14/2014. Otherwise, no adverse events occurred.
Patient was given Moderna covid vaccine then 10 minutes later she complained that she was having difficulty swallowing. She was given a dose of epinephrine and sent to Emergency Room via EMS.
15aug91 feet & palms itching, urticaria;  17aug91 edema - mouth & tongue, difficulty breathing.
Pain, itching at sight noticed upon wakening 7/30/14. Redness and swelling in a 3.5 inch diameter around site injection and a red ring on outer edge noticed 7/31/2013 upon wakening. Gave Benadryl and topical cortisone - which relieved itchiness only.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 9:34 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 9:34 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient age was reported as 70.29. No concomitant medication was reported. Batch number 031L20A underwent temperature excursion on 12-Feb-2021 with temperature 35 degrees Fahrenheit at 11:00 AM . This vial was moved to fridge on 09-Feb-2021 and beyond use date for the vial was reported as 10-Mar-2021. Product moved to clinic on 12-Feb-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken by using a traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.
Menstrual cycle started 4 days early with heavier than usually flow and more painful cramps. Typically cycle is never off by more than on day.
Headache / ongoing; Fatigue / ongoing; Arm soreness; This case was reported by a consumer and described the occurrence of pain in arm in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th December 2020, the patient received Shingrix (intramuscular). In December 2020, less than a week after receiving Shingrix, the patient experienced pain in arm. On 21st December 2020, the patient experienced headache and fatigue. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the headache and fatigue were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, headache and fatigue to be related to Shingrix.  Additional details were reported as follows: The patient received the Shingrix dose and experienced arm soreness for a day or two after receiving the vaccine. The patient experienced headache and fatigue and ongoing till the time of report. The reporter did not consent to follow up.
Swelling to (L) upper arm started within 24 hrs. Went to ER 1/23/13, follow up with pediatrician 1/24/13 AM. Went to ER again later in day 1/24/13 and was admitted overnight. Discharged 1/25/13. Reported fever on 1/24/13. ER visit with severe pain. NO abscess was seen. Called an arthus reaction by MD treating in hospital.
It started the evening after I received my dose, and it was the same experience after I received my second dose in January. I experienced intense epigastric pain that spread to my back all up my back. It lasted for 12 hours, I used over the counter antacid with no effect. The next day I called my primary care, they called in Carafate. Then I went to see my gastrointestinal doctor.
oral mouth sores-red sores on oral mucosa. Pt was treated for aphthous ulcer of mouth with kenolog paste. At time of visit had rash for 4 days. No shortness of breath, angioedema, chest pain, difficulty swallowing, fever. Pt had similar reaction after 3rd dose of Moderna (booster) but never reported it as he didnt realize it could have been from the vaccine.
Initial and follow up information has been received from a registered nurse concerning a 12 year old female student who in July 2007, was vaccinated with a 0.5mL first dose of Gardasil. The patient experienced no problems after the first dose. On 26-SEP-2007 the patient was vaccinated in the left arm with a second dose of Gardasil (lot# 658558/1061U). There were no illnesses at the time of the vaccination.  On 27-SEP-2007 the patient experienced pain at the injection site, dizziness, and "wobbly/shakey legs." No fever was reported. The patient was instructed to lie down, rest, and call the office with an update on her condition later in the day on 27-SEP-2007. The patient called the office. The patient recovered on an unspecified date. At the time of the report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested.  Additional information is not expected.
numbers are high/numbers (sugar) are (now) very high; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (numbers are high/numbers (sugar) are (now) very high) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Blood pressure high. Concomitant products included HYDROCODONE, INSULIN, METFORMIN, PIOGLITAZONE HYDROCHLORIDE (ACTOS), GLYBURIDE and LISINOPRIL for an unknown indication.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (numbers are high/numbers (sugar) are (now) very high). The patient was treated with INSULIN for Blood sugar increased, at an unspecified dose and frequency. At the time of the report, BLOOD GLUCOSE INCREASED (numbers are high/numbers (sugar) are (now) very high) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient noticed at morning that his sugar was up and also up a little last night. Wife said he had to take some insulin. Patient's blood sugar was up again at work and he had to take more (insulin).
Chills; headache; muscle pain; fever; nausea; running nose; This is a spontaneous report from a contactable other hcp. A 51-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:El3246, expiry date unknown), via an unspecified route of administration on 23Dec2020 at a SINGLE DOSE then (lot: El3246) via an unspecified route of administration on 13Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. The patient experienced chills, headache, muscle pain, fever, nausea and running nose on 14Jan2021. Treatment was not received for all events. The outcome of the events was not recovered.
Approximately 10 to 15 minutes after vaccination, patient reported feeling dizzy with slight headache. Also reported tingling starting on the left fingers and hand that progressed to tingling (not numbness) up both arms and both sides of the upper body.   Body felt "weird".  Headache progressed to a "pounding headache" with pain in the eyes because the headache is "so bad".  Patient reports feeling tired and "drained".    Patient being frequently monitored by nursing staff.
Attenuated breakthrough case of chicken pox clinically diagnosed 11-28-06. Child vaccinated with varivax on 06-07-02. 15-20 lesions.
I had a stroke. I have no idea if its related. I also spent 7  days in rehab.
This spontaneous report as received from a pharmacy technician refers to a 4 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 6-MAR-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
Extremely swollen left arm from elbow to shoulder. Swelling into left scapula and left side of neck. Entire upper arm painful & Red.  Unable to move arm up or away from body or straighten at elbow. Feeling faint when standing and Nausea from pain. Saw primary physician 2-28-2006; prescribed Medrol Dose Pack.  Elbow still swollen on 3-3-06.